Comparison of PNA Clamping-assisted Fluorescence Melting Curve Analysis and PNA Clamping in Detecting Mutations in Matched Tumor Tissue, Cell Block, Pleural Effusion and Blood of Lung Cancer Patients With Malignant Pleural Effusion.

Background/Aim: This study compared the efficacy of PANAMutyper (TM), a novel technology that integrates PNAClamp (TM) and PANA S-Melting (TM) , and PNACIamp (TM) alone for the detection of EGFR mutations in lung cancer patients. Materials and Methods: PANAMutyper (TM) and PNAClamp (TM) were used to assess the EGFR mutation status in tissue, cell block, pleural effusion, and blood samples of 90 lung cancer patients with malignant pleural effusion. Results: PANAMutyper (TM) detected more EGFR mutations than PNAClamp (TM) , especially in body fluids (pleural effusion and serum). Patients with additional EGFR mutations detected using PANAMutyper (TM) had a favorable response to EGFR-tyrosine kinase inhibitor (TKI) treatment. Conclusion: The diagnostic performance of PANAMutyper (TM) was superior to that of PNAClamp (TM) for the detection of EGFR mutations. It was also better at identifying lung cancer patients with malignant pleural effusion who were likely to benefit from EGFR-TKI treatment.